2016 ACR/ARHP Annual Meeting Archives - Page 62 of 219

Abstract Number: 2152

S100A11 Protein Is Increased in Rheumatoid Arthritis and Is Associated with Disease Activity and Inflammation
Abstract Number: 172

S100A8/A9 Produced during Experimental Osteoarthritis Induces a Systemic Decrease in BM Monocytes and Increases Ly6C High Monocytes Locally in the Joint
Abstract Number: 173

S100A8/A9, a Potent Serum and Molecular Imaging Biomarker for Synovial Inflammation and Joint Destruction in Seronegative Experimental Arthritis
Abstract Number: 1613

Safe and Effective Tocilizumab Therapy in Elderly Patients with Rheumatoid Arthritis
Abstract Number: 392

Safety and Clinical Response of Weekly Adalimumab in the Treatment of Juvenile Idiopathic Arthritis, Pediatric Chronic Uveitis and Other Childhood Rheumatic Diseases
Abstract Number: 3009

Safety and Effectiveness of Adalimumab±Methotrexate for the Treatment of Polyarticular Juvenile Idiopathic Arthritis
Abstract Number: 2896

Safety and Effectiveness of Hyperbaric Oxygen Therapy for Systemic Sclerosis Ulcers
Abstract Number: 958

Safety and Efficacy of ABT-122, a TNF and IL-17–Targeted Dual Variable Domain (DVD)–Ig™, in Psoriatic Arthritis Patients with Inadequate Response to Methotrexate: Results from a Phase 2 Trial
Abstract Number: 1590

Safety and Efficacy of Baricitinib in Elderly Patients with Moderate to Severe Rheumatoid Arthritis
Abstract Number: 3247

Safety and Efficacy of Belimumab with Background Mycophenolate for Early Diffuse Cutaneous Systemic Sclerosis: A Randomized, Placebo Controlled, Pilot Trial
Abstract Number: 687

Safety and Efficacy of Certolizumab Pegol over 204 Weeks in Patients with Axial Spondyloarthritis, Including Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis
Abstract Number: 211

Safety and Efficacy of Febuxostat in Advanced CKD Patients with Hyperuricemia
Abstract Number: 1622

Safety and Efficacy of Iguratimod in Patients with Active Rheumatoid Arthritis: A Multicenter, Single-Arm, Open-Label, Real World Study
Abstract Number: 1043

Safety and Efficacy of Intravenous Golimumab in Adult Patients with Active Ankylosing Spondylitis: Results through Week 28
Abstract Number: 255

Safety and Efficacy of Long-Term Canakinumab Therapy in Patients with CAPS: Final Results from Beta-Confident Registry
Abstract Number: 739

Safety and Efficacy of Rituximab in the Treatment of Refractory Systemic Lupus Erythematosus: Results from a National Register
Abstract Number: 3033

Safety and Efficacy of Single Dose VAY736 (anti-BAFF-R mAb) in Patients with Primary Sjögren’s Syndrome (pSS)
Abstract Number: 969

Safety and Efficacy of Subcutaneous Tocilizumab in Early Systemic Sclerosis: Results from the Open-Label Period of a Phase 2 Randomized, Controlled Trial
Abstract Number: 721

Safety and Efficacy of Switching from Originator to CT-P13 Infliximab Biosimilar in Patients Affected By Spondyloarthritis. a 6-Month Observational Study
Abstract Number: 385

Safety of Adalimumab in Pediatric Patients with Polyarticular Juvenile Idiopathic Arthritis, Enthesitis-Related Arthritis, Psoriasis, and Crohn’s Disease
Abstract Number: 330

Safety of Denosumab in Postmenopausal Osteoporosis and in Cancer and Bone Metastase Treatment: A Systematic Review and Meta-Analysis
Abstract Number: 2625

Safety of Multiple Retreatments with Rituximab in Real Life: Long Term Registry Data from 1984 Patients with Rheumatoid Arthritis
Abstract Number: 1624

Safety of Surgery in Patients Treated with Tocilizumab for Rheumatoid Arthritis : Data from a French Registry
Abstract Number: 2641

Safety of Synthetic and Biological Dmards: Slr Informing the Update of the EULAR Recommendations for the Management of RA
Abstract Number: 3000

Safety of the Knee Needle Arthroscopy: A Review of 1136 Procedures in 919 Patients
Abstract Number: 2622

Safety, Pharmacokinetics, and Biomarker Profile from Phase 1 Clinical Trials of Healthy Volunteers Treated with GDC-0853, a Highly Selective Reversible Oral Bruton’s Tyrosine Kinase (BTK) Inhibitor
Abstract Number: 144

Safety, Tolerability and Feasibility of Minimally Invasive Ultrasound-Guided Synovial Biopsyof Wrist and Metacarpophalangeal Joints – an Ultrasound Follow-up Study
Abstract Number: 1610

Safety, Tolerability, and Dose-Dependent Inhibition of T-Cell-Dependent Antibody Response with MEDI4920, a Novel, Engineered CD40L Antagonist: Results of a Single-Ascending Dose Study in Healthy Volunteers
Abstract Number: 665

Salivary Gland Secretome: A Novel Tool to Identify Biomarkers of Dryness and Immunopathology in Primary Sjogren’s Syndrome and Non-Autoimmune Sicca Patients
Abstract Number: 261

Sarcoidosis Is Associated with Increased Risk of Venous Thromboembolism: A Population-Based Study
Abstract Number: 1631

Sarilumab Dose Reduction in an Open-Label Extension Study in RA Patients
Abstract Number: 3179

Scale Structure and Measurement Properties of a Disease Specific Patient-Reported Outcome for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Abstract Number: 2717

Sclerostin and Dickkopf-1 but Not Periostin May Have a Role in Psoriatic Arthritis
Abstract Number: 3160

Scoring Syndesmophytes on CT Spine Images of Patients with Radiographic Axial Spondyloarthritis from the Sensitive Imaging of Axial Spondyloarthritis (SIAS) Cohort
Abstract Number: 2050

Screening for and Management of Comorbidities after a Nurse-Led Program: Results of a 3 Year Longitudinal Study in 776 Established RA Patients
Abstract Number: 1173

Screening for Depression and Anxiety in an Outpatient Rheumatology Clinic Using Validated Self-Applied Questionnaires
Abstract Number: 1901

Screening for Pulmonary Arterial Hypertension in an Unselected Prospective Systemic Sclerosis Cohort
Abstract Number: 1493

Screening Patterns for Hyperlipidemia Among Patients with Rheumatoid Arthritis Based on Patterns of Care from By Primary Care Physicians, Rheumatologists or Both
Abstract Number: 1797

Seasonal Differences in the Disease Onset and the Exacerbation of Systemic Lupus Erythematosus
Abstract Number: 262

Seasonal Variation in Incidence of Sarcoidosis: A Population-Based Study 1976-2013
Abstract Number: 3163

SEC16A and Intracellular Trafficking Abnormalities in Axial Spondyloarthritis
Abstract Number: 1738

Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Adalimumab Using a Matching-Adjusted Indirect Comparison
Abstract Number: 1729

Secukinumab for the Treatment of Psoriatic Arthritis: Comparative Effectiveness Versus Infliximab Using a Matching-Adjusted Indirect Comparison
Abstract Number: 961

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis through 3 Years: Efficacy and Safety Results from a Phase 3 Trial
Abstract Number: 2757

Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis: 104 Weeks Results from a Phase 3 Trial
Abstract Number: 695

Secukinumab Sustains Individual Clinical Responses over Time in Patients with Active Ankylosing Spondylitis: 2-Year Results from a Phase 3 Randomized Placebo-Controlled Trial
Abstract Number: 2251

Secukinumab Vs Adalimumab for the Treatment of Ankylosing Spondylitis: A Cost per Responder Analysis at 52 Weeks from the US Perspective
Abstract Number: 3125

Secular Trend of Premature Mortality in Gout: A Contrast from Rheumatoid Arthritis
Abstract Number: 1719

Secular Trends in Treatment Patterns for Psoriasis and Psoriatic Arthritis: A Population-Based Cohort Study
Abstract Number: 2512

Secular Trends of Sustained Remission in Rheumatoid Arthritis, a Nationwide Register Study in Sweden
Abstract Number: 3146

Selective Deletion of a Pathogenic Subset Synovial Fibroblasts Attenuates Synovial Inflammation
Abstract Number: 2790

Selective Disruption of Estrogen Receptor Alpha Expression in Dendritic Cells of Lupus-Prone Mice Results in Increased Female-Specific Death
Abstract Number: 462

Selective Inhibition of MMP9 Using a Monoclonal Antibody As a Therapeutic Strategy for Rheumatoid Arthritis
Abstract Number: 1668

Selective Inhibition of Tumor Necrosis Factor-α Receptor 2 (TNFR2) Activity Alleviates Psoriasiform Inflammation in Mouse Models
Abstract Number: 15L

Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis vulgaris and Normalizes Skin Pathology Via Concurrent Regulation of IL-17 and IL-10 Levels
Abstract Number: 1433

Self-Perception Reporting to Healthcare Professionals: Do Individuals with Systemic Sclerosis Report Quality of Life Changes Accurately?
Abstract Number: 2201

Self-Reported Breathlessness on Exertion Is Associated with Poor Outcomes Among Women with Systemic Lupus Erythematosus (SLE)
Abstract Number: 2203

Self-Reported Childhood Maltreatment and Traumatic Events Among Israeli Patients Suffering from Fibromyalgia and Rheumatoid Arthritis
Abstract Number: 2754

Self-Reported Physical Activity Questionnaire in Axial Spondyloarthritis: Modification of the Squash
Abstract Number: 1054

Self-Reported Psychological Impact and Coping Strategies of Men with RA
Abstract Number: 1276

Sensitive SPECT/CT Imaging of Fibroblast Activation Protein Expression after Anti-IL-22 Treatment in Experimental Arthritis
Abstract Number: 3185

Sensitivity Analysis for the Smoking Paradox in the Development of Psoriatic Arthritis Among Psoriasis Patients
Abstract Number: 494

Sensitivity and Specificity of 14-3-3η, Anti-CEP-1 and Anti-Sa Antibodies in a Cohort of Seronegative and Suspected Rheumatoid Arthritis (RA) Patients from a Community Rheumatology Practice
Abstract Number: 2007

Sensitivity and Specificity of Autoantibodies Against CD74 in Early Axial Spondyloarthritis
Abstract Number: 2942

Sequencing of 16S rRNA Reveals a Distinct Salivary Microbiome Signature in Behcet’s Disease
Abstract Number: 2059

Serine/Arginine-Rich Splicing Factor 1 (SRSF1) Is a Novel Factor in T Cell Homeostasis and Its Selective Loss in T Cells Causes Autoimmunity and Lupus-like Nephritis
Abstract Number: 2629

Serious Adverse Events in Patients with RA Taking Abatacept Compared with Other Dmards. Results from a US-Wide Safety Registry
Abstract Number: 2049

Serious Infections in RA Offspring Exposed to Tumor Necrosis Factor Inhibitors
Abstract Number: 2612

Sero-Positivity for Rheumatoid Factor Is an Independent Predictor for Achievement of Good EULAR Response at 24 Weeks in ACPA Positive Rheumatoid Arthritis Patients Treated with Abatacept: Results from Japanese Multicenter Registry
Abstract Number: 2613

Seropositivity for RF or ACPA Predicts Long Term Drug Retention with Rituximab, but Not with Abatacept and Tocilizumab : Long-Term Registry Data in 4498 Patients with Rheumatoid Arthritis
Abstract Number: 2506

Seropositivity Predicts Bone Biomarker Change in an Inception Cohort of Rheumatoid Arthritis Patients Treated-to-Target with Combination Conventional DMARD Therapy
Abstract Number: 644

Seroprevalence and Its Impact on Radiographic Damage in Korean Rheumatoid Arthritis Patients Starting Biologics
Abstract Number: 1526

Serum y-Neuropeptide Levels and Its Relationship with Body Fat Mass and Clinical Characteristics in Rheumatoid Arthritis
Abstract Number: 2822

Serum 25-Hydroxyvitamin D3 Levels and Flares of Systemic Lupus Erythematosus: A Longitudinal Cohort Analysis
Abstract Number: 1363

Serum Adipokines in Juvenile Dermatomyositis Are Associated with Disease Activities and Cardiac Function
Abstract Number: 564

Serum Adiponectin and Body Composition in a Group of Patients with Rheumatoid Arthritis: Relationship Between Disease Parameters
Abstract Number: 2856

Serum C5a Is Elevated in Lupus Nephritis and in Neuropsychiatric Systemic Lupus Erythematosus through Different Mechanisms
Abstract Number: 1677

Serum Complement C3 Component As a Potential Disease Activity Marker in Psoriatic Arthritis
Abstract Number: 2328

Serum Ferritin Levels, Distribution of Ground Glass Opacities and New Development of Lung Infiltration during Therapy Predict Prognosis of Interstitial Lung Disease in Anti-MDA5 Ab Positive Dermatomyositis
Abstract Number: 2907

Serum KL-6 Levels in Interstitial Lung Diseases (ILDs) Associated to Connective Tissue Diseases (CTDs)
Abstract Number: 2892

Serum Level of KL-6, a Biomarker of Interstitial Lung Disease (ILD), Is Higher in Diffuse SSc Than in Limited SSc and RA Even When the Activity of ILD Is Low
Abstract Number: 1529

Serum Levels of P-Glycoprotein Are Associated with Disease Activity in Rheumatoid Arthritis
Abstract Number: 2347

Serum Levels of Resistin Are Associated with Synovial Inflammation and Knee Structural Changes in Patients with Symptomatic Knee Osteoarthritis
Abstract Number: 3250

Serum MCP-1 Levels Predict Long-Term Progression of Interstitial Lung Disease in Systemic Sclerosis
Abstract Number: 2585

Serum MMP-3 and OPG As Predictors of Response to Traditional Dmards in a Treatment NaïVe Early Rheumatoid Arthritis Cohort
Abstract Number: 1544

Serum Omentin-1 Levels and Metabolic Syndrome in Women with Rheumatoid Arthritis
Abstract Number: 364

Serum Sclerostin Levels in Rheumatoid Arthritis (RA) and Its Correlation with Disease Activity and Bone Mineral Density
Abstract Number: 2287

Serum Urate and Its Association with Endothelial Dysfunction in Young Adults
Abstract Number: 2297

Serum Urate and Its Association with Race in Young Adults: Baseline Analysis from a Randomized Clinical Trial
Abstract Number: 294

Serum Urate Levels Predict Joint Space Narrowing in Non-Gout Patients with Medial Knee Osteoarthritis
Abstract Number: 2158

Serum Uric Acid Is Positively Associated with Pulmonary Function in Korean Health Screening Examinees: A Cross-Sectional Study
Abstract Number: 205

Serum Uric Acid Lowering Treatment Appears Unnecessary during Hemodialysis
Abstract Number: 1225

Serum Uric Acid Testing Practices over Five Years Among Incident Gout Cases
Abstract Number: 1332

Severe Complications and Immunosuppressive Treatments in 33 Patients with Relapsing Polychondritis
Abstract Number: 827

Severe Gastrointestinal Disease in Early Systemic Sclerosis Is Associated with an Increased Risk of Mortality
Abstract Number: 2408

Severe Juvenile Arthritis Associated with a De Novo Gain-of-Function Germline Mutation in MYD88
Abstract Number: 1975

Severity and Improvement of Morning Stiffness Independently Associate with Tenosynovitis in Patients with Rheumatoid Arthritis
Abstract Number: 986

Sex-Specific Associations Between Improvement in Gait Mechanics and Improvement in Pain, Function, and Abductor Strength after Total Hip Arthroplasty
Abstract Number: 485

Sexual Dimorphism of Popliteal Lymph Node Collapse As a Biomarker of Disease Progression in the Tumor Necrosis Factor Transgenic Mouse Model of Rheumatoid Arthritis
Abstract Number: 466

Sexually Dimorphic Dysbiosis of Gut Microbiota in Tumor Necrosis Factor Transgenic Mice with Inflammatory-Erosive Arthritis
Abstract Number: 2157

Share the Fate: Fibroblast-like Synoviocyte Cell-to-Cell Organelle Transfer Is Directed By the Inflammatory Microenvironment
Abstract Number: 1559

Shared Genetic Predisposition in Rheumatoid Arthritis–Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis: A Genetic Association Study
Abstract Number: 2477

Short Term Clinical Response to Initial Treatment with High Versus Low Dose Methotrexate in Mono- and Combination Therapy in Early Rheumatoid Arthritis Patients
Abstract Number: 980

Short-Course Glucocorticoids in ANCA-Associated Vasculitis: A Proof of Concept Study
Abstract Number: 228

Sick Leave and Disability Pension in Working-Age Gout Patients before and after Diagnosis – a Population Based Case-Control Study
Abstract Number: 1753

Signal Transducer and Activator of Transcription (STAT) 3 Regulates Tcrαβ+CD4-CD8- T Cells in Systemic Lupus Erythematosus (SLE)
Abstract Number: 2508

Significant Improvement of Rheumatoid Arthritis (RA) Outcome with Repeat Application of Disease Management (SSDM) Mobiles Tools: A Cohort Study of RA Patients in China
Abstract Number: 696

Significantly Reduced Recurrence Rate of Acute Anterior Uveitis in Ankylosing Spondylitis during Treatment with Golimumab
Abstract Number: 1302

Silent Progression in Patients with Rheumatoid Arthritis: Is DAS28 Remission an Insufficient Goal in RA? Results from the German Remission-PLUS Cohort
Abstract Number: 2614

Similar Rates of Death, Serious Infections, Cancers, Major Cardiovascular Events in Patients Treated with Abatacept, Rituximab and Tocilizumab: Long-Term Registry Data in 4498 Patients with Rheumatoid Arthritis
Abstract Number: 2133

Simulation of Cartilage Damage in Osteoarthritis Using Patient-Derived Induced Pluripotent Stem Cells
Abstract Number: 2548

Single 1g Infusion Vs Double 1g Infusion of Rituximab in Rheumatoid Arthritis in a Large Teaching Hospital: Potential Clinical Benefits and Financial Savings
Abstract Number: 1843

Single Cell Expression Quantitative Trait Loci (eQTL) Analysis of Established SLE-Risk Loci in Lupus Patient Monocytes
Abstract Number: 806

Single Cell Rnaseq Defines a Unique Transcriptome Profile for Myofibroblasts in the Skin of Patients with Systemic Sclerosis
Abstract Number: 2419

Single-Cell Analysis of CD163 mRNA and Protein Expression By Primeflow™ in Polarized Monocyte and Macrophage Populations
Abstract Number: 1615

Sirukumab, an Anti–IL-6 Cytokine Monoclonal Antibody, Significantly Improves Physical Function and Reduces Morning Stiffness in Patients with Active Rheumatoid Arthritis Despite Anti-TNF Therapy: Results from a Global, Randomized, Placebo-Controlled, Phase 3 Trial
Abstract Number: 672

Sjogren Big Data Project: Influence of Geolocation on the Phenotypic Expression at Diagnosis in 8310 Patients (North-to-South Gradient)
Abstract Number: 673

Sjögren’s Syndrome (SS): The Role of Traditional (SS-A/SS-B) and Novel Antibodies in Diagnosis
Abstract Number: 1216

Sjogren’s Syndrome-Associated Transcripts Show Correlation with Objective Measures of Dryness
Abstract Number: 2807

Skin and Muscle Sodium Concentrations in Patients with Systemic Lupus Erythematosus: A Proof of Concept Study
Abstract Number: 210

Skin Events with Febuxostat in Gout Patients and Previous Skin Reactions to Allopurinol. a Retrospective Review
Abstract Number: 1816

SLE and Uctd in the Rheumatology Informatics System for Effectiveness (RISE) Registry
Abstract Number: 1836

SLE Bone Marrow Contains Factors That Promote Type I Interferon Activation
Abstract Number: 2876

SLE Serum Impairs NO Production in Huvecs through Induction of eNOS Uncoupling
Abstract Number: 2872

SLE Subjects Express High Levels of Intracellular Interferon-β That Acts in an Autocrine Fashion to Promote Survival of Transitional Stage B Cells
Abstract Number: 410

Sleep and Its Relationship to Pain and Disease Activity in Turkish Children and Adolescent with Juvenile Idiopathic Arthritis
Abstract Number: 3251

Sleep and Physical Activity: A Nationwide Survey Among People with Rheumatic Disease in Ireland
Abstract Number: 2403

Sleep Disruption in Children with Chronic Pain
Abstract Number: 1536

Sleep Disturbance in Patients with Rheumatoid Arthritis – a Cross-Section Study
Abstract Number: 2761

Sleep Disturbance in Psoriatic Disease: Prevalence and Associated Factors
Abstract Number: 1759

Sleep Disturbance Is Associated with Worsening Patient-Reported Outcomes over Two Years in Systemic Lupus Erythematosus (SLE)
Abstract Number: 1532

Sleep Hygiene Practices and Associations with Patient-Reported Outcomes in Rheumatoid Arthritis
Abstract Number: 2337

Sleep Quality, Disturbances and Physical Activity: A Nationwide Survey Among Health Professionals on Their Engagement with Irish People Who Have Rheumatic Disease
Abstract Number: 42

Small Fibre Neuropathy Biopsies (SFN) in Primary Fibromyalgia Revealed Predominant Association with Metabolic Syndrome (in addition to other known treatable causes of SFN) but No Clear Distinction Related to Biopsy Results
Abstract Number: 45

Small Fiber Neuropathy in Rheumatology Clinics
Abstract Number: 1579

Small Rnaseq Reveals Different Plasma miRNA Signature in Patients with RA and SLE: A Pilot Study
Abstract Number: 3068

Smoking and Excess Weight Attenuate Rate of Improvement over First 3 Years in Early RA
Abstract Number: 2762

Smoking and Severity of Psoriatic Arthritis
Abstract Number: 1775

Smoking As a Predictor of Cutaneous Activity in Systemic Lupus Erythematosus
Abstract Number: 1995

Smoking Is Associated with Unfavorable Flare/ Remission Pattern in Patients with Rheumatoid Arthritis
Abstract Number: 1799

Smoking, Antiphospholipid Antibodies and Thrombosis in SLE
Abstract Number: 3187

Societal Costs and Patients’ Experience of Health Inequities from Psoriatic Arthritis: A Danish Cohort Study
Abstract Number: 3236

Socio-Demographic and Clinical Factors Influencing Generic and Disease-Specific Quality of Life in Patients with Systemic Lupus Erythematosus: Results of a Prospective Multicenter Study
Abstract Number: 1262

Sociodemographic and Clinical Correlates of Physical Therapy Utilization in Adults with Symptomatic Knee Osteoarthritis
Abstract Number: 1252

Socioeconomic Status and Not Race Associated with Delay in Diagnosis and Treatment of Rheumatoid Arthritis
Abstract Number: 124

Socioeconomic-Demographic, Disease Activity, Treatment and Immunologic Variables Affect B Cell Subtypes in Systemic Lupus Erythematosus
Abstract Number: 561

Sodium Intake Is Increased in Patients with Early Rheumatoid Arthritis and Is Associated with Radiographic Erosions
Abstract Number: 17L

Sofosbuvir Plus Daclatasvir for Hepatitis C Virus Associated Cryoglobulinemia Vasculitis
Abstract Number: 1016

Soluble BAT-3: A New Biomarker for Antisynthetase Syndrome
Abstract Number: 1657

Soluble Biomarkers May Differentiate Psoriatic Arthritis from Osteoarthritis
Abstract Number: 2626

Soluble CD206 Plasma Levels Decreases with Treatment and Reflects Anti-Tnfa Discontinuation in Rheumatoid Arthritis
Abstract Number: 2279

Soluble Urate: A Direct Mediator of Bone Turnover?
Abstract Number: 2699

Spa-Associated HLA-B*27 Subtypes Accumulate More in Endoplasmic Reticulum (ER) Compartment and in Association with β2-Microglobulin (β2m) Than Non-Associated HLA-B Alleles
Abstract Number: 3121

Specific Antibody Subphenotypes in Rheumatoid Arthritis Are Associated with Unique HLA-DRB1 Residues at Position 11
Abstract Number: 2930

Specific Metabolic and Functional Changes in Peripheral CD8+ T Cells Specifically Distinguish RA from PSA and SPA
Abstract Number: 3228

Specific T Cell and B Cell Distributions Characterize Subgroups of Patients with Primary Sjögren’s Syndrome and Are Associated with Disease Activity and Pro-Inflammatory Cytokine Expression
Abstract Number: 2177

Specificity of Spinal Pain Features in Assessment and Classification of Spondyloarthritis
Abstract Number: 1878

Speckle Tracking Echocardiography: A Sensitive Technique for Detecting Early Left Ventricular Dysfunction in Patients with Systemic Sclerosis
Abstract Number: 1599

Speed of Onset of Effect on Patient-Reported Outcomes Assessed through Daily Electronic Patient Diaries in the Baricitinib Phase 3 RA Clinical Program
Abstract Number: 5L

Speed of Remission with the Use of Voclosporin, MMF and Low Dose Steroids: Results of a Global Lupus Nephritis Study
Abstract Number: 274

Splicing Factor Proline/Glutamine-Rich Is a Novel Autoantigen of Dermatomyositis and Associated with Anti-Melanoma Differentiation-Associated Gene 5 Antibody.
Abstract Number: 2336

Splinting for Trigger Finger. Short Term Effects
Abstract Number: 3164

Spondyloarthritis Pathogenesis Involves Interplay Between Gut Microbiota and Genetic Background
Abstract Number: 688

Spondyloarthritis Research Consortium of Canada (SPARCC) Baseline MRI SI Joint Score ≥2 Better Predicts Response to Golimumab Than Does Assessment of Spondyloarthritis International Society (ASAS) MRI Positivity in Nonradiographic Axial Spondyloarthritis
Abstract Number: 1209

Sporadic Hemophagocytic Lymphohistiocytosis (sHLH): A Polygenic Disease? a Report of French National, Prospective, Cohort of 205 Patients
Abstract Number: 3019

Sputum Antibodies to Individual Citrullinated Protein/Peptide Antigens Are Elevated in Subjects at-Risk of Future RA and Subjects with Established Disease
Abstract Number: 2560

Sputum Antibody to Malondialdehyde-Acetaldehyde Adduct in Subjects with Established Rheumatoid Arthritis
Abstract Number: 2901

SSc and the Significance of Blood Group Antigens
Abstract Number: 1229

Stakeholder Needs Assessment for a New Model of Care for Pediatric Rheumatology in Ontario
Abstract Number: 1826

STAT3 Phosphorylation Mediates the Stimulatory Effects of Interferon Alpha on B Cell Differentiation and Activation in SLE
Abstract Number: 2178

Statin Use and Increased Risk of Musculoskeletal Conditions: A Retrospective Cohort Study with Propensity Score-Matching
Abstract Number: 1017

Statistical Simulation Using Data from the Foundation for the National Institute of Health/Osteoarthritis Initiative Biomarkers Consortium to Evaluate the Clinical Utility of Prognostic Knee Osteoarthritis Biomarkers in Designing a Knee Osteoarthritis Clinical Trial
Abstract Number: 671

Steered Screening for Sjögren Syndrome in Patients with Sicca Syndrome. Role of Salival Beta-2 Microglogulin
Abstract Number: 1347

Steroid-Responsive Encephalopathy Associated with Autoimmune Thyroiditis: Characteristics, Treatment and Outcome in 251 Cases from the Literature
Abstract Number: 630

Strategies for Biological Drug Quantification in Biological Drug Immune Responses
Abstract Number: 1040

Stressful Life Events : A Trigger for Rheumatoid Arthritis Onset within a Year. a Case-Control Study
Abstract Number: 2572

Study of Two Biomarkers of Biological Age in the Blood of Patients with Rheumatoid Arthritis
Abstract Number: 1835

Study on the Expression of NOD2 in Lupus Nephritis and Its Potential Signaling Pathway
Abstract Number: 684

Subchondral Bone Sclerosis on Computed Tomography – Does It Have Any Value in the Diagnosis of Inflammatory Sacroiliitis or Is It a Non-Specific Finding?
Abstract Number: 2137

Subchondral Bone Structure and Pain Behaviors in Collagenase Induced Noninflammatory Monoarthritis in Mice
Abstract Number: 1721

Subclinical Atherosclerosis Evolution during 5 Years of Anti-Tnfalpha Treatment in Psoriatic Arthritis Patients: Preliminary Data
Abstract Number: 1000

Subclinical Cytomegalovirus Viremia Is Associated with Increased Nosocomial Infections and Prolonged Hospitalization in Patients with Systemic Autoimmune Diseases
Abstract Number: 1782

Subclinical Myocarditis in Systemic Lupus Erythematosus Patients without Cardiovascular Disease
Abstract Number: 2739

Subclinical Ungueal Distrophy in Patients with Psoriasis without Joint Involvement: Is There Any Role for Nail Ultrasound?
Abstract Number: 948

Subcutaneous Abatacept in Patients with Polyarticular-Course Juvenile Idiopathic Arthritis and Inadequate Response to Biologic or Non-Biologic Disease-Modifying Antirheumatic Drugs: Pharmacokinetics, Efficacy and Safety
Abstract Number: 521

Subcutaneous Adipose Tissue from Rheumatoid Arthritis Patients Is Characterized By an Abundance of Macrophages That Are Associated with Autoantibodies, Systemic Inflammation, and Immunomodulation
Abstract Number: 2559

Subgingival Microbiome Signatures in Patients with Established Rheumatoid Arthritis and Osteoarthritis
Abstract Number: 1481

Success Rate of Blood Pressure Goal Achievement in Patients with Inflammatory Joint Diseases
Abstract Number: 2061

Successful Treatment of Murine Lupus Nephritis with Helminths Related Tuftsin-Phosphorylcholine Compound and Its Effect on the Microbiota
Abstract Number: 2316

Successful Treatment of Statin-Induced Autoimmune Myopathy without Corticosteroids
Abstract Number: 1024

Superior Gains in Bone Mineral Density and Estimated Strength at the Hip for Romosozumab Compared with Teriparatide in Women with Postmenopausal Osteoporosis Transitioning from Bisphosphonate Therapy: Results of a Phase 3, Open-Label Clinical Trial
Abstract Number: 1524

Suppletion Therapy May be Warranted in RA Patients with Co-Existent Subclinical Hypothyroidism
Abstract Number: 1442

Suppression of Acute Arthritis By N-Methyl-3,4-Dichloropropionaniline (N-MeDCPA), a Reversible Orai Calcium Channel Inhibitor
Abstract Number: 1460

Suppression of Cholesterol Levels and Impairment in Cholesterol Efflux By HDL in K/BxN Mice Is Associated with a Specific Cytokine/Chemokine Profile
Abstract Number: 2788

Suppression of IL-1 Signaling Ameliorates Dermatitis in a Murine Model of Systemic Lupus Erythematosus
Abstract Number: 2283

Suppression of Monosodium Urate (MSU) Crystals-Induced Inflammatory Response By Inhibiting TGF-β Activated Kinase 1 (TAK1)
Abstract Number: 2259

Suppression of Monosodium Urate Crystal-Induced Cytokine Production Via Inhibition of Histone Deacetylases 1/2
Abstract Number: 175

Suppressor of Cytokine Function One (SOCS1) Is Elevated in Non-Classical Monocytes and Correlates with Disease Activity in Systemic Lupus Erythematosus Patients
Abstract Number: 3245

Surfactant Protein D and Krebs Von Den Lungen-6 Predict Severity of Systemic Sclerosis-Related Interstitial Lung Disease in Two Independent Cohorts
Abstract Number: 2949

Surgical Method for Aortic Root Involvement of Behcet Disease
Abstract Number: 1166

Survey on the Understanding and Practice of T2T for Nurses Engaged in Medical Treatment of Rheumatoid Arthritis
Abstract Number: 828

Survival and Health-Related Quality of Life in Incident Systemic Sclerosis Related Pulmonary Arterial Hypertension: A Multicentre Australian Cohort Study
Abstract Number: 910

Survival Benefit of Statin Use in Ankylosing Spondylitis and Psoriatic Arthritis: A General Population-Based Cohort Study
Abstract Number: 1641

Survival of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
Abstract Number: 2794

Sustained Complete Remission in Lupus Nephritis
Abstract Number: 604

Sustained Efficacy and Comparable Safety and Immunogenicity after Transition to SB5 (an Adalimumab Biosimilar) Vs. Continuation of SB5 or Reference Adalimumab (Humira®) in Patients with Rheumatoid Arthritis: Results of Phase III Study
Abstract Number: 1733

Sustained Efficacy of Ixekizumab in Patients with Moderate-to-Severe Plaque Psoriasis and Concomitant Psoriatic Arthritis
Abstract Number: 1416

Sustained Improvement in Documentation of Disease Activity Measurement As a Quality Improvement Project at an Academic Rheumatology Clinic
Abstract Number: 3138

Sustained Improvement in Follow-up of Hypertension in Rheumatology Patients: Results of an Intervention Sustainability Assessment
Abstract Number: 2227

Sustained Remission and Relapse Rate after Non-Conventional DMARD Withdrawal in Patients with Rheumatoid Arthritis
Abstract Number: 2619

Sustained Suppression of Peripheral Biomarkers By Mavrilimumab but Not Golimumab in Anti-Tumor Necrosis Factor-Inadequate Responders: An Exploratory Analysis in the Phase IIb Earth Explorer 2 Clinical Trial
Abstract Number: 2364

Swimming May Associate with Less Osteoarthritis: Data from the Osteoarthritis Initiative
Abstract Number: 626

Switching Biologic Therapy in a Population of Rheumatoid Arthritis Patients
Abstract Number: 3107

Switching from Anabolic to Catabolic Metabolism – a Novel Immunomodulatory Therapy in RA
Abstract Number: 639

Switching to Biosimilars in Rheumatology: Evidence-Based Practice
Abstract Number: 3162

Symmetric and Asymmetric Sacroiliitis Are Associated with Different Major Histocompatibility Class I Alleles in Psoriatic Arthritis
Abstract Number: 1514

Symptoms of Depression and Anxiety Predict Worse Disease Activity and Functional Disability in a Cohort of Established Rheumatoid Arthritis Patients
Abstract Number: 2153

Syndecans Mediate Rantes/CCL5 Induced MMP-1 and MMP-13 Expression in Rheumatoid Arthritis Synovial Fibroblasts
Abstract Number: 676

Syndesmophytes in the Thoracic Spine in Ankylosing Spondylitis As Detected By Computed Tomography and Association with Lumbar Radiographic Involvement
Abstract Number: 1091

Synergistic Immunoregulatory Effects of IL-10 and TGF-β on Humoral Immunity
Abstract Number: 2363

Synovial Changes Detected By Ultrasound and Its Association with Knee Pain: A Population-Based Case Control Study
Abstract Number: 1099

Synovial Exosomes Induce Osteoclast Differentiation in Rheumatoid arthritis
Abstract Number: 543

Synovial Features of Rheumatoid Arthritis and Psoriatic Arthritis Differ in Patients in Clinical and Ultrasound Remission after Anti-TNF Therapy
Abstract Number: 573

Synovial Fibroblast-Neutrophil Interactions Promote Pathogenic Adaptive Immunity in Rheumatoid Arthritis
Abstract Number: 2110

Synovial Fibroblasts Regulate B Cell Survival Via B Cell Activating Factor of the TNF Family (BAFF)
Abstract Number: 587

Synovial Immunophenotype and Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis Patients: Relationship to Treatment Response and Radiological Prognosis
Abstract Number: 153

Synovial Immunophenotype and Ultrasonography: A Contemporaneous Study of Different Compartments of the Knee Joint
Abstract Number: 3218

Synovial Mast Cells Associate with High Disease Activity and Predict Radiographic Progression at 12 Months in Patients with Early Rheumatoid Arthritis
Abstract Number: 1030

Synovial Tissue Resident Macrophages Play the Protective Role in the Development of Inflammatory Arthritis in CD11c-Flip-KO Mice
Abstract Number: 134

Synovitis Assessed By the German 7-Joint Ultrasound Score (US7S) Is Associated with the Reversible Activity-Related Component of Physical Disability in Patients with Rheumatoid Arthritis
Abstract Number: 157

Synovitis of Sternoclavicular and Peripheral Joints Can be Detected By Ultrasound in Patients with SAPHO Syndrome
Abstract Number: 1403

Systematic Appraisal of the American College of Rheumatology Clinical Practice Guidelines
Abstract Number: 1161

Systematic Development of a Patient-Centered Strategy to Improve Tight Control in Daily Clinical Practice
Abstract Number: 1404

Systematic Review and Appraisal of Quality Measures for Inflammatory Arthritis
Abstract Number: 2945

Systematic Review: “Efficacy and Safety of Biological Versus Immunosuppressive Therapy Compared to Placebo in the Treatment of Uveitis Associated with BehçEt’s Disease.”
Abstract Number: 121

Systemic Lupus Erythematosus (SLE) Is a Salient Cause of Premature Mortality in the United States: A Sex-Based Exploration
Abstract Number: 792

Systemic Lupus Erythematosus (SLE) Responder Index [SRI(4)] Response Is Associated with Global Benefit in Patients with Moderate to Severe SLE
Abstract Number: 1762

Systemic Lupus Erythematosus and the Evaluation of Poor Sleep
Abstract Number: 1760

Systemic Lupus Erythematosus in Immigrants: Results from the 1000 Canadian Faces of Lupus Study
Abstract Number: 2849

Systemic Lupus Erythematosus Patients with Antibodies Against U1-Ribonucleoprotein Exhibit a Specific Pattern of Disease Manifestations
Abstract Number: 1811

Systemic Lupus Erythematosus: Detailed Anatomy of a Cohort (follow-up for more than 35 years).
Abstract Number: 1323

Systemic Manifestations Associated with Parvovirus B19 Infection in Adults: A Retrospective Study in 23 Patients